US1638511089
US1638511089
Chemours Company (The)
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 5.808.000.000 | 5.782.000.000 | 0.4% |
| Cost of Revenue | 4.906.000.000 | 4.640.000.000 | 5.7% |
| Gross Profit | 902.000.000 | 1.142.000.000 | 21.0% |
| 930.000.000 | 721.000.000 | 29.0% | |
| Operating Income | -28.000.000 | 421.000.000 | 106.7% |
| Pretax Income | -277.000.000 | 106.000.000 | 361.3% |
| Net Income Common Stockholders | -386.000.000 | 69.000.000 | 659.4% |
| -- | -- | -- | |
| -- | -- | -- |